Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

NCT03286244 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

DRUG: CM082 plus paclitaxel

Sponsor

AnewPharma